Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Orthopediatrics (KIDS) FCF Margin (2016 - 2025)

Orthopediatrics (KIDS) has disclosed FCF Margin for 10 consecutive years, with 15.83% as the latest value for Q4 2025.

  • On a quarterly basis, FCF Margin fell 418.0% to 15.83% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.75%, a 646.0% increase, with the full-year FY2025 number at 6.75%, up 646.0% from a year prior.
  • FCF Margin was 15.83% for Q4 2025 at Orthopediatrics, up from 5.58% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 20.01% in Q4 2024 to a low of 40.81% in Q2 2022.
  • A 5-year average of 19.71% and a median of 22.25% in 2025 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: tumbled -2116bps in 2023, then soared 5026bps in 2024.
  • Orthopediatrics' FCF Margin stood at 11.57% in 2021, then grew by 21bps to 9.09% in 2022, then tumbled by -233bps to 30.25% in 2023, then surged by 166bps to 20.01% in 2024, then fell by -21bps to 15.83% in 2025.
  • Per Business Quant, the three most recent readings for KIDS's FCF Margin are 15.83% (Q4 2025), 5.58% (Q3 2025), and 22.77% (Q2 2025).